PATENT CLAIM ANALYSIS

Application Number: 15973088
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
Disclosed herein are methods for decreasing Ataxin 2 mRNA and protein expression. Such methods are useful to treat, prevent, or ameliorate Ataxin 2 associated diseases, disorders, and conditions. Such Ataxin 2 associated diseases include spinocerebellar ataxia type 2 (SCA2), amyotrophic lateral sclerosis (ALS), and parkinsonism.

Claim (Index 38):
The method of  claim 31 , wherein the administering distributes the single-stranded modified oligonucleotide to the Purkinje cells.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 93.0
- Lexical Diversity: 1.56757
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15127352', '15127358', '14436030', '14436024', '15028626']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8310839345194894
- 35 USC 102 Novelty (BERT): 0.5903871891074877
- Combined Prediction Score: 0.8070142599782892
- Mean Citation Score: 421.951742
- Max Citation Score: 586.1248
- Similarity Product: 425.9494387374878

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test